By Ruth Whittington ([email protected]) Part 3 – Conducting an observational study Last month, we looked at the differences between observational studies and randomised controlled trials (RCTs). Here, we look at…
Details
By David Woods ([email protected]) Question: “How many people work in the public sector?” Answer: “About half of them.” It’s an old one, to be sure, but it has its echo…
Details
By David Woods ([email protected]) If you feel that emails are inundating you, and you yearn for the days of the quill pen, help is at hand. In her recent book…
Details
By Amy Rothman Schonfeld ([email protected]) One year after its first conference, the American Society of Health Economists (ASHE) is clearly thriving. Its membership has grown to more than 800, planning…
Details
By David Woods ([email protected]) The theme of this year’s international ISPOR meeting – held on May 20–23 in Arlington, Virginia, USA – was “new tools, new audiences for health outcomes…
Details
By Ruth Whittington ([email protected]) Part 2 – How do observational studies and randomised controlled trials differ? Last month, I described observational studies and where they fit into the hierarchy of…
Details
By David Woods ([email protected]) “An opportunity and a challenge”. That’s what Alan Bakst found when he became Director of Health Economics and Outcomes Research at TAP pharmaceuticals in Chicago in…
Details
By David Woods ([email protected]) HOC editor David Woods has just returned from attending two healthcare congresses. Fourth Annual World Health Care Congress (WHC), Washington, DC, 22–24 April A panel on…
Details
Many economists think their profession has something to say about almost everything. This is because nearly everything can be thought of in terms of incentives and constraints.
Details
By Ruth Whittington ([email protected]) This is the first in a series of four articles about observational studies. It’s our impression that observational studies (also known as “naturalistic studies”) are becoming…
Details